AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells. Morimoto K, Yamada T, Hirai S, Katayama Y, et al. Cancer Lett 2024;587:216692.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Morimoto K, Yamada T, Hirai S, Katayama Y, et al. AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells. Cancer Lett 2024;587:216692.
PMID: 38342232